Literature DB >> 3095226

Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.

R Cameron, J D Waterfield.   

Abstract

MRL-lpr mice and their congenic counterparts MRL-+ spontaneously develop an autoimmune disease that resembles systemic lupus erythematosus in humans. The two strains, although congenic, differ by a considerable number of disease parameters, reflecting the expression of the lpr autosomal recessive gene. One paradox that has developed out of the work utilizing the congenic mice is that the gene responsible for lymphoproliferation also appears to be responsible for the inability of T cells to respond to proliferative signals in vitro. In this paper we investigated a possible lpr gene-encoded macrophage defect in these mice. It was found, however, that both the MRL-+ and MRL-lpr mice failed to divide in response to Con A, the lack of division correlating with an inability to secrete the growth promoter interleukin-2. In MRL-+ mice and young MRL-lpr mice this non-responsiveness was corrected by the addition of normal CBA PEC. The defect could not be explained by a failure of MRL-+ or MRL-lpr peritoneal exudate cells to quantitatively or qualitatively provide a source of interleukin-1 to Con A-activated T cells or by the possibility that the peritoneal exudate cells were blocked in their function by the presence of sera-derived autoantibodies and/or immune complexes on their membranes. We postulate that the inability of T cells to proliferate in MRL congenic mice can be explained by two defects: the failure of antigen-presenting cells in MRL-+ and MRL-lpr to provide the necessary signals to immunocompetent T cells, this defect not being associated with the lpr gene, and the lpr gene controlled outgrowth of a unique T-cell population that cannot respond in our assay system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3095226      PMCID: PMC1453160     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Immunoglobulin synthesis in the lungs and caudal mediastinal lymph node of sheep.

Authors:  A B Gorin; J Gould
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 3.  Etiopathogenesis of murine SLE.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

Review 4.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease.

Authors:  L H Glimcher; A D Steinberg; S B House; I Green
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats.

Authors:  L Kobilinsky; W D Hardy; N K Day
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

Authors:  J Kaye; S Gillis; S B Mizel; E M Shevach; T R Malek; C A Dinarello; L B Lachman; C A Janeway
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

8.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.

Authors:  A Altman; A N Theofilopoulos; R Weiner; D H Katz; F J Dixon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes.

Authors:  A N Theofilopoulos; R A Eisenberg; M Bourdon; J S Crowell; F J Dixon
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

10.  Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.

Authors:  D Wofsy; E D Murphy; J B Roths; M J Dauphinée; S B Kipper; N Talal
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  5 in total

1.  Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse.

Authors:  L M Warner; T Cummons; L Nolan; S N Sehgal
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

2.  Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS).

Authors:  A Katzav; Y Kloog; A D Korczyn; H Niv; D M Karussis; N Wang; R Rabinowitz; M Blank; Y Shoenfeld; J Chapman
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Expression of an EL4 tumour-associated determinant on subpopulations of murine T cells in normal and lympho-proliferative autoimmune mice.

Authors:  J D Waterfield; M Fairhurst
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

4.  Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.

Authors:  J L Fan; K Himeno; S Tsuru; K Nomoto
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects.

Authors:  J D Waterfield; M Fairhurst; R Chu; J G Levy
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.